Compare PICS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PICS | PLSE |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | 2015 |
| Metric | PICS | PLSE |
|---|---|---|
| Price | $11.61 | $20.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $22.00 | $22.00 |
| AVG Volume (30 Days) | ★ 291.9K | 226.3K |
| Earning Date | 05-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.65 | $840.00 |
| Revenue Next Year | $39.85 | $287.54 |
| P/E Ratio | $29.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.88 | $12.56 |
| 52 Week High | $18.49 | $26.30 |
| Indicator | PICS | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 42.18 | 43.43 |
| Support Level | $9.88 | $17.32 |
| Resistance Level | $14.65 | $20.40 |
| Average True Range (ATR) | 0.83 | 1.39 |
| MACD | -0.08 | -0.30 |
| Stochastic Oscillator | 10.48 | 12.82 |
PicS NV is a digital payments company. The company operates a peer-to-peer (P2P) transfer platform that enables individuals to send money via mobile devices. It provides digital wallets, instant payments (Pix), P2P transfers, credit cards, loans, investments, insurance, and SMB payment solutions. The company has four reportable segments: Consumer Banking, Small and Medium-Sized Businesses, Audiences and Ecosystem Integration, and Institutional. The majority of the company's revenue is derived from the Consumer Banking segment, which generates revenue from various transaction activities occurring in the digital wallet, such as Pix, peer-to-peer (P2P) transfers, and bill payments.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.